This episode features recent updates presented at the 2022 European Society for Medical Oncology (ESMO) Congress in Paris, France. SOLO1 study survival data, PAOLA data, and information about novel, early-phase drugs and their practice implications are reviewed by three speaker experts.

Speakers:
Ashley Stuckey, MD (moderator)
Women & Infants Hospital Brown University

Paul DiSilvestro, MD
Warren Alpert Medical School Brown University
Women & Infants Hospital of Rhode Island and Care New England Health System

Premal Thaker, MD
Washington University School of Medicine

Claire Friedman, MD
Memorial Sloan Kettering Cancer Center